News Chart Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 14:01:43 2026-07-24 EDT			5-day change	1st Jan Change
477.84 ^USD	+1.01%		-1.50%	+5.51%

07-21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT
07-20	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating	MT

68d6df61eb076a76435fe5a15875f3bd.X7YRYH2PrYyjhdWTIa3_q72w25tJBR4JsolXk7RmVlw.PtNVLT_ElOfx9Jric-XI2tH0jq0Af2g-hdtv3MwfMjkt3iQ6K_bY_sTA7Q~c52d45e51dd6cb67d877a109a8acdf77